<DOC>
	<DOCNO>NCT00707226</DOCNO>
	<brief_summary>After focus many year intraocular pressure ( IOP ) primary risk factor , recently impact ocular blood flow get consideration pathophysiology glaucoma . The circadian change intraocular pressure ( IOP ) well investigate , diurnal variation ocular blood flow yet evaluate , especially glaucomatous eye . This study perform investigate circadian variation ocular blood flow assess laser interferometric fundus pulsation amplitude ( FPA ) laser Doppler flowmetry ( LDF ) glaucomatous eye topical antiglaucoma therapy 8:00 , 12:00 , 17:00 21:00 , compare circadian variation ocular blood flow glaucomatous eye variation healthy eye relate blood flow variation IOP variation .</brief_summary>
	<brief_title>Circadian Variations Ocular Blood Flow Glaucomatous Normal Eyes</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>For glaucoma patient : Medical control Primary Open Angle Glaucoma history 2 year Topical medication betablockers ( timolol , betaxolol , levobunol ) IOP medication &lt; 22 mmHg ( medical history IOP &gt; 22 mmHg ) Visual field testing : mild glaucomatous defect ( Humphrey 302 MD &gt; 10 ) Optic nerve head : C/Dratio 0.4 0.9 ametropy &lt; 3 dpt Normal finding medical history physical examination unless investigator considers abnormality clinically irrelevant For age match control subject : Normal finding medical history physical examination unless investigator considers abnormality clinically irrelevant Normal laboratory value unless investigator considers abnormality clinically irrelevant Normal ophthalmic finding , ametropy &lt; 3 dpt . For glaucoma patient : History trabeculectomy laser trabeculoplasty Any ocular disease possible vascular involvement diabetic retinopathy , age relate macular disease , retinal vein artery occlusion . Uncontrolled systemic hypertension ( define systolic blood pressure &gt; 170 mmHg diastolic blood pressure &gt; 100 mmHg ) Diabetes mellitus For age match control subject : abuse alcoholic beverage , participation clinical trial 3 week precede study Symptoms clinically relevant illness 3 week first study day History presence gastrointestinal , liver kidney disease Ametropy &gt; 3 dpt</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Laser Doppler flowmetry</keyword>
	<keyword>Choroidal blood flow</keyword>
	<keyword>Fundus pulsation amplitude</keyword>
	<keyword>Intraocular Pressure</keyword>
</DOC>